Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide

Citation
Ve. Walker et al., Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide, CARCINOGENE, 21(9), 2000, pp. 1661-1669
Citations number
49
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CARCINOGENESIS
ISSN journal
01433334 → ACNP
Volume
21
Issue
9
Year of publication
2000
Pages
1661 - 1669
Database
ISI
SICI code
0143-3334(200009)21:9<1661:BOEAEA>2.0.ZU;2-X
Abstract
The purposes of the present study were: (i) to investigate the potential us e of several biomarkers as quantitative indicators of the in vivo conversio n of ethylene (ET) to ethylene oxide (EO); (ii) to produce molecular dosime try data that might improve assessment of human risk from exogenous ET expo sures. Groups (n = 7/group) of male F344 rats and B6C3F1 mice were exposed by inhalation to 0 and 3000 p.p.m. ET for 1, 2 or 4 weeks (6 h/day, 5 days/ week) or to 0, 40, 1000 and 3000 p.p.m. ET for 4 weeks. N-(2-hydroxyethyl) valine (HEV), N7-(2-hydroxyethyl) guanine (N7-HEG) and Hprt mutant frequenc ies were assessed as potential biomarkers for determining the molecular dos e of EO resulting from exogenous ET exposures of rats and mice, compared wi th background biomarker values. N7-HEG was quantified by gas chromatography coupled with high resolution mass spectrometry (GC-HRMS), HEV was determin ed by Edman degradation and GC-HRMS and Hprt mutant frequencies were measur ed by the T cell cloning assay. N7-HEG accumulated in DNA with repeated exp osure of rodents to 3000 p.p.m. ET, reaching steady-state concentrations ar ound 1 week of exposure in most tissues evaluated (brain, fiver, lung and s pleen). The dose-response curves for N7-HEG and HEV were supralinear in exp osed rats and mice, indicating that metabolic activation of ET was saturate d at exposures greater than or equal to 1000 p.p.m. ET. Exposures of mice a nd rats to 200 p.p.m. EO for 4 weeks las positive treatment controls) led t o significant increases in Hprt mutant frequencies over background in splen ic T cells from exposed rats and mice, however, no significant mutagenic re sponse was observed in the Hprt gene of ET-exposed animals. Comparisons bet ween the biomarker data for both unexposed and ET-exposed animals, the dose -response curves for the same biomarkers in EO-exposed rats and mice and th e results of the rodent carcinogenicity studies of ET and EO suggest that t oo little EO arises from exogenous ET exposure to produce a significant mut agenic response or a carcinogenic response under standard bioassay conditio ns.